Treatment of rheumatoid arthritis with CD99 antagonists

Details for Australian Patent Application No. 2004272093 (hide)

Owner Entelos, Inc.

Inventors Wennerberg, Leif Gustaf; Scherrer, Didier A.; Michelson, Seth G.; Hurez, Vincent Jacques

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004272093

PCT Pub. Number WO2005/025618

Priority 60/502,345 11.09.03 US

Filing date 10 September 2004

Wipo publication date 24 March 2005

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/025618 Priority application(s): WO2005/025618

8 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272098-Oleamide-containing composition for animal consumption

2004272083-System and method for risk based authentication